Archana P Lamichhane1, Jamie L Crandell2, Lindsay M Jaacks2, Sarah C Couch2, Jean M Lawrence2, Elizabeth J Mayer-Davis2. 1. From the Department of Nutrition, Gillings School of Global Public Health (APL), the Department of Nutrition, Gillings School of Global Public Health and School of Medicine (EJM-D), and the Departments of Nursing and Biostatistics (JLC), University of North Carolina, Chapel Hill, NC; the Department of Nutritional Sciences, University of Cincinnati Medical Center, Cincinnati, OH (SCC); the Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA (JML), and the Hubert Department of Global Health, Emory University, Atlanta, GA (LMJ). archana_lamichhane@unc.edu. 2. From the Department of Nutrition, Gillings School of Global Public Health (APL), the Department of Nutrition, Gillings School of Global Public Health and School of Medicine (EJM-D), and the Departments of Nursing and Biostatistics (JLC), University of North Carolina, Chapel Hill, NC; the Department of Nutritional Sciences, University of Cincinnati Medical Center, Cincinnati, OH (SCC); the Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA (JML), and the Hubert Department of Global Health, Emory University, Atlanta, GA (LMJ).
Abstract
BACKGROUND: Improved glycated hemoglobin (Hb A1c) delays the progression of microvascular and macrovascular complications in individuals with type 1 diabetes (T1D). We previously showed that higher baseline intakes of n-3 (ω-3) fatty acids and leucine are associated with preserved β cell function 2 y later in youth with T1D. OBJECTIVE: In the current study, we extend this work to explore the longitudinal associations of nutritional factors with Hb A1c in youth with T1D. DESIGN: We included 908 T1D youth with baseline and follow-up Hb A1c measurements. Nutritional factors assessed at baseline were as follows: breastfeeding status and timing of complimentary food introduction; intakes of leucine, carbohydrates, protein, fat, and fiber estimated from a food-frequency questionnaire (FFQ); and plasma biomarkers for vitamins D and E, eicosapentaenoic acid (EPA), and docosahexaenoic acid. We fit linear regression models adjusted for baseline Hb A1c, sociodemographic variables, diabetes-related variables, time between baseline and follow-up visits, saturated fat, physical activity, and for FFQ-derived nutrients, total calories. The vitamin D model was further adjusted for season and body mass index z score. RESULTS: The mean ± SD age and diabetes duration at baseline was 10.8 ± 3.9 y and 10.1 ± 5.8 mo, respectively. A total of 9.3% of participants had poor Hb A1c (value ≥9.5%) at baseline, which increased to 18.3% during follow-up (P < 0.0001). Intakes of EPA (β = -0.045, P = 0.046), leucine (β = -0.031, P = 0.0004), and protein (β = -0.003, P = 0.0002) were significantly negatively associated with follow-up Hb A1c after adjustment for confounders. Intake of carbohydrates was significantly positively (β = 0.001, P = 0.003) associated with follow-up Hb A1c after adjustment for confounders. CONCLUSIONS: Several nutritional factors may be associated with Hb A1c during early stages of disease progression in youth recently diagnosed with T1D. In addition to the overall role of major macronutrients such as carbohydrates and protein, leucine and n-3 fatty acid intakes, such as of EPA, may be important for long-term glycemic control.
BACKGROUND: Improved glycated hemoglobin (Hb A1c) delays the progression of microvascular and macrovascular complications in individuals with type 1 diabetes (T1D). We previously showed that higher baseline intakes of n-3 (ω-3) fatty acids and leucine are associated with preserved β cell function 2 y later in youth with T1D. OBJECTIVE: In the current study, we extend this work to explore the longitudinal associations of nutritional factors with Hb A1c in youth with T1D. DESIGN: We included 908 T1D youth with baseline and follow-up Hb A1c measurements. Nutritional factors assessed at baseline were as follows: breastfeeding status and timing of complimentary food introduction; intakes of leucine, carbohydrates, protein, fat, and fiber estimated from a food-frequency questionnaire (FFQ); and plasma biomarkers for vitamins D and E, eicosapentaenoic acid (EPA), and docosahexaenoic acid. We fit linear regression models adjusted for baseline Hb A1c, sociodemographic variables, diabetes-related variables, time between baseline and follow-up visits, saturated fat, physical activity, and for FFQ-derived nutrients, total calories. The vitamin D model was further adjusted for season and body mass index z score. RESULTS: The mean ± SD age and diabetes duration at baseline was 10.8 ± 3.9 y and 10.1 ± 5.8 mo, respectively. A total of 9.3% of participants had poor Hb A1c (value ≥9.5%) at baseline, which increased to 18.3% during follow-up (P < 0.0001). Intakes of EPA (β = -0.045, P = 0.046), leucine (β = -0.031, P = 0.0004), and protein (β = -0.003, P = 0.0002) were significantly negatively associated with follow-up Hb A1c after adjustment for confounders. Intake of carbohydrates was significantly positively (β = 0.001, P = 0.003) associated with follow-up Hb A1c after adjustment for confounders. CONCLUSIONS: Several nutritional factors may be associated with Hb A1c during early stages of disease progression in youth recently diagnosed with T1D. In addition to the overall role of major macronutrients such as carbohydrates and protein, leucine and n-3 fatty acid intakes, such as of EPA, may be important for long-term glycemic control.
Authors: J N Kostraba; K J Cruickshanks; J Lawler-Heavner; L F Jobim; M J Rewers; E C Gay; H P Chase; G Klingensmith; R F Hamman Journal: Diabetes Date: 1993-02 Impact factor: 9.461
Authors: Brittni Frederiksen; Miranda Kroehl; Molly M Lamb; Jennifer Seifert; Katherine Barriga; George S Eisenbarth; Marian Rewers; Jill M Norris Journal: JAMA Pediatr Date: 2013-09 Impact factor: 16.193
Authors: John P Bantle; Judith Wylie-Rosett; Ann L Albright; Caroline M Apovian; Nathaniel G Clark; Marion J Franz; Byron J Hoogwerf; Alice H Lichtenstein; Elizabeth Mayer-Davis; Arshag D Mooradian; Madelyn L Wheeler Journal: Diabetes Care Date: 2008-01 Impact factor: 19.112
Authors: S N Balk; D A J M Schoenaker; G D Mishra; M Toeller; N Chaturvedi; J H Fuller; S S Soedamah-Muthu Journal: Eur J Clin Nutr Date: 2015-07-15 Impact factor: 4.016
Authors: Kimberly A Driscoll; Karen D Corbin; David M Maahs; Richard Pratley; Franziska K Bishop; Anna Kahkoska; Korey K Hood; Elizabeth Mayer-Davis Journal: Curr Diab Rep Date: 2017-08 Impact factor: 4.810
Authors: Daria Igudesman; Jamie Crandell; Victor W Zhong; Angelica Cristello Sarteau; Anna R Kahkoska; Karen Corbin; Richard Pratley; Michael R Kosorok; David M Maahs; Elizabeth J Mayer-Davis Journal: Pediatr Diabetes Date: 2020-10-05 Impact factor: 3.409
Authors: Margaret A Powers; Robin L Gal; Crystal G Connor; Meg Mangan; David M Maahs; Mark A Clements; Elizabeth J Mayer-Davis Journal: Diabetes Res Clin Pract Date: 2018-05-26 Impact factor: 5.602
Authors: Dana Dabelea; Katherine A Sauder; Elizabeth T Jensen; Amy K Mottl; Alyssa Huang; Catherine Pihoker; Richard F Hamman; Jean Lawrence; Lawrence M Dolan; Ralph D' Agostino; Lynne Wagenknecht; Elizabeth J Mayer-Davis; Santica M Marcovina Journal: Ann N Y Acad Sci Date: 2021-02-05 Impact factor: 6.499
Authors: R Perchard; L Magee; A Whatmore; F Ivison; P Murray; A Stevens; M Z Mughal; S Ehtisham; J Campbell; S Ainsworth; M Marshall; M Bone; I Doughty; P E Clayton Journal: Endocr Connect Date: 2017-04-05 Impact factor: 3.335
Authors: Lauren L O'Mahoney; Jamie Matu; Oliver J Price; Karen M Birch; Ramzi A Ajjan; Diane Farrar; Robyn Tapp; Daniel J West; Kevin Deighton; Matthew D Campbell Journal: Cardiovasc Diabetol Date: 2018-07-07 Impact factor: 9.951